Managed Care Research In Action

(EDU-R2) Get to the Point: A Managed Care Pharmacy Research Podium Session

Tuesday, April 13, 2021

11:00 AM – 12:00 PM

ACPE UAN: | Contact Hours: 1 | Activity Type: Knowledge-based

Faculty(s)

Elizabeth A. Ibiloye, MPH, MEd, MS

Graduate Student
University of Texas at Austin
Austin, TX
Christopher Manz, MD, MSHP

Instructor in Medicine
Dana-Farber Cancer Institute
Boston, MA
Carrie Mcadam-Marx, PhD, RPh

Professor
University of Nebraska Medical Center
Omaha, NE
Shiyu Zhang, MS, PhD candidate

Graduate Student
University of Texas at Austin
Austin, TX

Moderator(s)

MM

Melissa McCart, PharmD, MS

Director, Global Health Economics and Outcomes Research
Xcenda
Palm Harbor, Florida

As the rate of scientific research continues to grow exponentially, people increasingly expect to consume information in shorter formats, which take less of their limited time. Thus, researchers must be able to tell their story in a concise manner that motivates an audience to seek more information about the project. In this high-energy session, authors will present their research findings using a rapid-presentation format — effectively serving as an advertisement for their posters that contain detailed information. Questions from the moderator and audience will simulate those from funding agencies, customers, and executive decision-makers that researchers may face in a practice environment.

The top four rated abstracts submitted to the AMCP 2021 Virtual affecting managed care pharmacy practice are selected for this prestigious podium session.

Featured poster presentations include:

• Gabapentinoid use and misuse among Texas Medicaid recipients.
• Patterns of treatment and survival for Medicare patients with metastatic lung cancer: setting the stage for the immunotherapy revolution
• Will Medicare Insulin Out-of-Pocket Limits Improve Adherence?
• Adherence and Healthcare Utilization in Patients with Hepatic Encephalopathy (HE)

Learning Objectives:

At the completion of this activity, participants should be able to:

Determine the prevalence of and identify factors associated with Gabapentinoid use and misuse among Texas Medicaid recipients.
Determine treatment patterns and survival population characteristics Medicare patients with metastatic non-small cell lung cancer after first line oral therapies were approved but before first- line immunotherapy.
Describe how insulin out-of-pocket costs for Medicare Advantage beneficiaries with diabetes may affect insulin non-adherence.
Compare adherence and healthcare resource utilization among patients receiving lactulose monotherapy, rifaximin monotherapy, and combination therapy.